ESPR Live signals | Maximize Profits with Getagraph.com

SELL 100982 min ago

@ $2.49

Issued: 13 Feb 2024 @ 15:31

Return: -16.06%

Previous signal: Feb 12 - 13:36

Previous signal: Buy

Return: -4.41 %

Live Chart Being Loaded With Signals

Commentary (23 Apr 2024 @ 16:00):

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol...

Stats
Today's Volume	4.93M
Average Volume	6.27M
Market Cap	356.17M
EPS	$0 ( 2024-02-27 )
Next earnings date	( $-0.170 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.030
ATR14	$0.00700 (0.33%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-14	Warren Eric	Buy	100 000	Common Stock
2024-03-14	Warren Eric	Buy	150 000	Stock Option (right to buy)
2024-03-14	Foody Joanne M.	Buy	150 000	Common Stock
2024-03-14	Foody Joanne M.	Buy	200 000	Stock Option (right to buy)
2024-03-14	Looker Benjamin	Buy	100 000	Common Stock

INSIDER POWER
98.70
Last 98 transactions
Buy: 4 476 078 \| Sell: 52 346

Volume Correlation

Long: 0.23 (neutral)

Short: 0.25 (neutral)

Signal:(45.245) Neutral

Esperion Therapeutics Inc Correlation

10 Most Positive Correlations
TCPC	0.971
STIM	0.97
BRKL	0.967
RVSB	0.965
CPTN	0.964
IBCP	0.958
HMST	0.958
FNWB	0.956
FRST	0.955
ISTR	0.955

10 Most Negative Correlations
ALBO	-0.958
PLPC	-0.957
MOTNU	-0.953
KBAL	-0.951
CMPI	-0.951
HUGE	-0.95
ZGNX	-0.949
ADMS	-0.949
LMB	-0.944
UNCY	-0.943

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Esperion Therapeutics Inc Correlation - Currency/Commodity

-0.03
( neutral )

-0.47
( neutral )

0.00
( neutral )

-0.38
( neutral )

Esperion Therapeutics Inc Financials

Annual	2023
Revenue:	$116.33M
Gross Profit:	$72.90M (62.67 %)
EPS:	$-2.03

Q4	2023
Revenue:	$32.25M
Gross Profit:	$20.79M (64.47 %)
EPS:	$-0.500

Q3	2023
Revenue:	$33.97M
Gross Profit:	$20.59M (60.62 %)
EPS:	$-0.370

Q2	2023
Revenue:	$25.79M
Gross Profit:	$19.00M (73.68 %)
EPS:	$-0.460

Financial Reports:

No articles found.

Esperion Therapeutics Inc

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.